EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Apigenin as an emerging hepatoprotective agent: current status and future perspectives

Cheng Wang, Xiaoli Feng, Wen Li, Li Chen, Xinming Wang, Yimiao Lan, Rong Tang, Ting Jiang, Lingli Zheng, Gang Liu

Frontiers in Pharmacology · 19.12.2024 · 15

DOI: 10.3389/fphar.2024.1508060 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 19.12.2024. Verfasst von Cheng Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medical, Chengdu Medical College, Chengdu, China. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 209 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Apigenin (C 15 H 10 O 5 , API) is a natural flavonoid widely found in vegetables, fruits, and plants such as celery, oranges, and chamomile. In recent years, API has attracted considerable attention as a dietary supplement due to its low toxicity, non-mutagenic properties and remarkable therapeutic efficacy in various diseases. In particular, evidence from a large number of preclinical studies suggests that API has promising effects in the prevention and treatment of a variety of liver diseases, including multifactorial liver injury, non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, liver fibrosis and liver cancer. This paper provides a comprehensive review of the progress of research into the therapeutic applications of API in liver diseases as of August 2024, based on literature retrieved from databases such as Web of Science, PubMed, CNKI, Google Scholar and ScienceDirect. The hepatoprotective effects of API involve multiple molecular mechanisms, including inhibition of inflammation, alleviation of hepatic oxidative stress, amelioration of insulin resistance, promotion of fatty acid oxidation, inhibition of liver cancer cell proliferation and differentiation, and induction of tumour cell apoptosis. More importantly, signaling pathways such as Nrf2, NF-κB, PI3K/Akt/mTOR, NLRP3, Wnt/β-catenin, TGF-β1/Smad3, AMPK/SREBP, PPARα/γ, MAPKs, and Caspases are identified as key targets through which API exerts its beneficial effects in various liver diseases. Studies on its toxicity and pharmacokinetics indicate that API has low toxicity, is slowly metabolized and excreted in vivo , and has low oral bioavailability. In addition, the paper summarises and discusses the sources, physicochemical properties, new dosage forms, and current challenges and opportunities of API, with the aim of providing direction and rationale for the further development and clinical application of API in the food, pharmaceutical and nutraceutical fields.

Schlagwörter

Stichwörter der Autor:innen

apigeninhepatoprotectionliver diseasenew formulationspharmacokineticstoxicity

Autor:innen und Institutionen

  • School of Clinical Medical, Chengdu Medical College, Chengdu, China.
  • Department of Pharmacy, The First Affiliated Hospital of Chengdu Medical College, Chengdu, China.
  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chengdu Medical College, Chengdu, China.
  • College of Foreign Languages and Cultures, Sichuan University, Chengdu, China.

Zitieren

APA

Wang, C., Feng, X., Li, W., Chen, L., Wang, X., Lan, Y., Tang, R., Jiang, T., Zheng, L., & Liu, G. (2024). Apigenin as an emerging hepatoprotective agent: current status and future perspectives. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1508060

Vancouver

Wang C, Feng X, Li W, Chen L, Wang X, Lan Y, et al. Apigenin as an emerging hepatoprotective agent: current status and future perspectives. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1508060

BibTeX
@article{Wang2024,
  author = {Wang, Cheng and Feng, Xiaoli and Li, Wen and Chen, Li and Wang, Xinming and Lan, Yimiao and Tang, Rong and Jiang, Ting and Zheng, Lingli and Liu, Gang},
  title = {Apigenin as an emerging hepatoprotective agent: current status and future perspectives},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1508060}
}
Kostenlos starten →